HSIE Results Daily 02nd May'26: IndiaMart, Kajaria Ceramics, and more Companies Result Analysis

HSIE Results Daily 02nd May’26: Mazagon Dock Shipbuilders, Laurus Labs, Mphasis, Aster DM Healthcare, Dr. Lal Pathlabs, Acutaas Chemicals, Kajaria Ceramics, CemIndia Projects, IndiaMART InterMESH

Mazagon Dock Shipbuilders

Mazagon Dock delivered a strong FY26, with revenue growth driven by faster execution and final platform deliveries. Quarterly margins expanded sharply on P17A deliveries. A deep order pipeline spanning submarines, frigates, and destroyers provides multi‑year revenue visibility. The acquisition of a majority stake in Colombo Dockyard adds MRO capabilities, helping diversify revenues and reduce cyclicality.

Laurus Labs

Laurus posted robust EBITDA growth, led by strong CDMO momentum and meaningful margin expansion driven by higher gross margins. The CDMO pipeline is supported by late‑phase projects, patented APIs, and capacity additions. Fermentation expansion, biosciences scale‑up, and investments in peptides broaden capabilities, while the generics business is expected to deliver steady growth alongside operating leverage.

Mphasis

Mphasis reported steady revenue growth with margin expansion, driven by strength in BFS and insurance, partly offset by weakness in TMT. Deal wins accelerated meaningfully, supported by rising AI‑led transformation demand. The deal pipeline reached a record level, signalling a shift toward function‑enhancing programs. The firm maintains disciplined margin guidance amid macro uncertainty.

Aster DM Healthcare

Aster DM delivered strong earnings growth, supported by hospital revenue expansion, stable occupancy, and higher ARPOB. Hospital margins improved despite initial losses from new facilities. Ongoing and planned bed additions across key clusters underpin medium‑term growth. The Quality Care Hospital platform continues to scale, with capacity expansion aligned to long‑term healthcare demand trends.

Dr. Lal Pathlabs

Dr. Lal Pathlabs reported steady growth driven by higher patient volumes and strong traction in preventive wellness offerings. Revenue expansion was supported by geographic reach, portfolio innovation in high‑complexity tests, and digital initiatives. The company continues to expand across tier‑2/3 regions and strengthen its presence through targeted acquisitions, while maintaining a stable pricing environment.

Acutaas Chemicals

Acutaas delivered a strong Q4, aided by higher‑margin CDMO revenues and operating leverage. Medium‑term growth is anchored by capacity ramp‑up, new CDMO molecules, and expansion in electrolyte and semiconductor chemicals. While revenue and profitability are expected to scale steadily, return metrics may moderate as capital intensity rises during the next expansion phase.

Kajaria Ceramics

Kajaria Ceramics posted strong revenue and profit growth, driven by higher tile volumes and sharp margin expansion from cost control initiatives. EBITDA benefited from operating leverage and lower fixed costs, while pricing remained largely stable. Management aims to sustain improved margins through continued efficiency gains and calibrated price actions amid elevated input cost conditions.

CemIndia Projects

CemIndia Projects outperformed on earnings due to strong metro project execution and realization of legacy claims, though some project delays persist. The order book remains diversified across infrastructure segments, providing resilience against sector‑specific slowdowns. Management is focused on higher‑value bidding, new segments such as data centres and ports, and improving execution consistency.

IndiaMART

InterMESH IndiaMART reported a softer quarter due to lower net subscriber additions and flat sequential ARPU, impacted by churn and macro headwinds. Collections growth moderated but remained positive. The company is increasing investments in marketing, technology, and AI‑led discovery to improve inquiry quality, seller retention, and platform trust, supporting a potential recovery in subscriber growth.

Download the Full Report: Click Here